On the basis of prevalence alone, testing the FMR1 gene in women with EM would have as good a detection rate for the premutation as screening children with developmental delay/learning difficulties has for the full mutation; therefore, many new families that segregate the mutation could be identified by testing women with EM. The gene discussed is FMR1; the disease is erythema multiforme.